Skip to main content
. 2010 Jul 4;26(2):709–715. doi: 10.1093/ndt/gfq382

Table 3.

Number (%) of patients in each intervention group with clinical improvement, clinical decline or no clinical change at post-intervention (T2) based on the calculated RCI

QOLT
ST
SC
Measure Improved Declined No change Improved Declined No change Improved Declined No change
QOLI 14 (64%)a 2 (9%) 6 (27%) 0 (0%)b 4 (20%) 16 (80%) 2 (10%)b 2 (10%) 16 (80%)
SF-36 PCS 1 (5%) 2 (9%) 19 (86%) 5 (25%) 5 (25%) 10 (50%) 2 (10%) 2 (10%) 16 (80%)
SF-36 MCS 8 (36%)a 1 (5%) 13 (59%) 3 (15%)b 5 (25%) 12 (60%) 2 (10%)b 3 (15%) 15 (75%)
POMS 10 (46%)a 2 (9%) 10 (46%) 6 (30%)a 1 (5%) 13 (65%) 2 (10%)b 3 (15%) 15 (75%)
HSCL 11 (50%)a 2 (9%) 9 (41%) 9 (45%)a 1 (5%) 10 (50%) 1 (5%)b 1 (5%) 18 (90%)
HRQoL mentally unhealthy days 6 (27%)a 0 (0%) 16 (73%) 4 (20%) 3 (15%) 13 (65%) 2 (10%)b 6 (30%) 12 (60%)
MSIS 6 (40%)a 0 (0%) 9 (60%) 3 (23%) 2 (15%) 8 (62%) 1 (9%)b 2 (18%) 8 (73%)

Different superscripts between columns labelled ‘Improved’ represent statistically significant differences between the treatment conditions (P < 0.05).

QOLI, Quality of Life Inventory total T score; SF-36 PCS, SF-36 Health Survey Physical Component Summary; SF-36 MCS, SF-36 Health Survey Mental Component Summary; POMS, Profile of Mood States total mood disturbance score; HSCL, Hopkins Symptom Checklist total score; MSIS, Miller Social Intimacy Scale total score.